REDPATH INTEGRATED PATHOLOGY

RedPath is a genomics-based cancer diagnostic company that provides comprehensive molecular analysis to resolve challenging diagnostic dilemmas. The company’s CLIA licensed, CAP certified laboratory delivers actionable diagnostic information that enables physicians to make personalized, effective treatment decisions for their patients.

RedPath Integrated Pathology is changing patient lives.  RedPath’s patented PathFinderTG® analysis integrates the original pathology evaluation with the power of genomics leading to a more complete diagnosis from existing specimens.  The results often provide dramatic information leading to an optimal course of treatment for each patient’s unique diagnosis